Is Revolution Medicines a Good Stock to Own?
Though it’s still quite early in the year, pharmaceutical startup…
Sell
20
GTBP Quote, Financials, Valuation and Earnings
Last price:
$0.75
Seasonality move
:
-5.56%
Day range:
$0.68 - $0.78
52-week range:
$0.54 - $3.85
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
59.35x
P/B ratio:
2.65x
Volume:
2.1M
Avg. volume:
2M
1-year change:
-67.99%
Market cap:
$7.9M
Revenue:
--
EPS (TTM):
-$3.40
Earnings Data
Next earnings date for GTBP
--
Most recent earnings per share
-$0.83
Missed by $0.83
(Sep 30/2025)
Consensus Estimate
--
(Sep 30/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
GTBP Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 12/31/2025 | Q4 | -- | -- | -- | -- | -- |
| 09/30/2025 | Q3 | -- | -- | -$0.83 | -- | -- |
| 08/14/2025 | Q2 | -- | -- | -$0.55 | -- | -- |
| 05/15/2025 | Q1 | -- | -- | -$0.33 | -- | -- |
| 03/26/2025 | Q4 | -- | -- | -$1.69 | -- | -- |
| 11/14/2024 | Q3 | -- | -- | -$1.53 | -- | -- |
| 08/14/2024 | Q2 | -- | -- | -$2.17 | -- | -- |
| 05/15/2024 | Q1 | -- | -- | -$1.64 | -- | -- |
| 03/26/2024 | Q4 | -- | -- | -$2.15 | -- | -- |
| 11/01/2023 | Q3 | -- | -- | -$1.77 | -- | -- |
| 08/11/2023 | Q2 | -- | -- | -$1.49 | -- | -- |
| 05/16/2023 | Q1 | -- | -- | -$0.17 | -- | -- |
| 03/28/2023 | Q4 | -- | -- | -$5.12 | -- | -- |
| 10/31/2022 | Q3 | -- | -- | -$6.58 | -- | -- |
| 08/11/2022 | Q2 | -- | -- | -$2.86 | -- | -- |
| 05/16/2022 | Q1 | -- | -- | -$5.02 | -- | -- |
| 03/28/2022 | Q4 | -- | -- | -$16.86 | -- | -- |
| 11/10/2021 | Q3 | -- | -- | -$5.21 | -- | -- |
| 08/13/2021 | Q2 | -- | -- | -$4.35 | -- | -- |
| 05/17/2021 | Q1 | -- | -- | -$54.82 | -- | -- |
| 12/31/2020 | Q4 | -- | -- | -$85.85 | -- | -- |
| 09/30/2020 | Q3 | -- | -- | -$19.11 | -- | -- |
| 06/30/2020 | Q2 | -- | -- | -$123.58 | -- | -- |
| 03/31/2020 | Q1 | -- | -- | -$12.43 | -- | -- |
| 12/31/2019 | Q4 | -- | -- | -$10.74 | -- | -- |
| 09/30/2019 | Q3 | -- | -- | -$259.12 | -- | -- |
| 06/30/2019 | Q2 | -- | -- | -$27.40 | -- | -- |
| 03/31/2019 | Q1 | -- | -- | -$45.02 | -- | -- |
| 12/31/2018 | Q4 | -- | -- | -$42.60 | -- | -- |
| 09/30/2018 | Q3 | -- | -- | -$2,397.58 | -- | -- |
| 06/30/2018 | Q2 | -- | -- | -$91.80 | -- | -- |
| 03/31/2018 | Q1 | -- | -- | -$102.00 | -- | -- |
| 12/31/2017 | Q4 | -- | -- | -$61.32 | -- | -- |
| 09/30/2017 | Q3 | -- | -- | -$4,156.48 | -- | -- |
| 06/30/2017 | Q2 | -- | -- | -$786,420.00 | -- | -- |
| 03/31/2017 | Q1 | -- | -- | -$4,033,080.00 | -- | -- |
| 12/31/2016 | Q4 | -- | -- | -$13,843.44 | -- | -- |
| 09/30/2016 | Q3 | -- | -- | -$19,890.00 | -- | -- |
| 06/30/2016 | Q2 | -- | -- | $9,180.00 | -- | -- |
| 03/31/2016 | Q1 | -- | -- | $128,520.00 | -- | -- |
GT Biopharma, Inc. Earnings Questions
-
How Much did GT Biopharma, Inc. Generate in Revenue Last Quarter?
GT Biopharma, Inc. reported -- worth of top line sales in its most recent quarter.
-
Did GT Biopharma, Inc. Beat Earnings Last Quarter?
GT Biopharma, Inc. announced earnings per share of -$0.83 which represents a miss of analyst forecast a -- per share.
-
Is GT Biopharma, Inc. Profitable?
GT Biopharma, Inc. reported -- that represents -- per share over the last quarter.
-
What is the Analyst Consensus for GT Biopharma, Inc. EPS Next Year?
GT Biopharma, Inc.'s earnings are forecast to decrease from -$6.94 per share to -- per share next year representing a decrease of -2.9%.
-
When is GT Biopharma, Inc.'s Earnings Date?
Currently, GT Biopharma, Inc. has not yet stated when its earnings date is, however, based on past estimates it's likely to take place on April 19, 2026.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Why Has Vistra Stock Gone Up?
Integrated power generation business Vistra (NYSE:VST) surprised investors recently when…
Why Is Amkor Stock Up So Much?
Semiconductor packaging and testing major Amkor (NASDAQ:AMKR) has started 2026…
Stock Ideas
Buy
56
Is NVDA Stock a Buy?
Market Cap: $4.5T
P/E Ratio: 63x
Buy
59
Is GOOG Stock a Buy?
Market Cap: $4T
P/E Ratio: 41x
Sell
48
Is GOOGL Stock a Buy?
Market Cap: $4T
P/E Ratio: 41x
Alerts
Buy
75
AGX alert for Jan 17
Argan, Inc. [AGX] is up 16.4% over the past day.
Buy
80
ASTS alert for Jan 17
AST Spacemobile, Inc. [ASTS] is up 14.32% over the past day.
Buy
84
IREN alert for Jan 17
IREN Ltd. [IREN] is up 11.35% over the past day.
